MIGRAINE THERAPEUTIC MARKET ANALYSIS

Migraine Therapeutic MarketSize and Trends

The global migraine therapeutic market was valued at US$ 4,785.8 Mn in 2021 and is forecast to reach a value of US$ 8,979.8 Mn by 2028 at a CAGR of 9.5% between 2022 and 2028. The global migraine therapeutic market is experiencing strong growth due to the rise in prevalence of migraine worldwide and rise in awareness about migraine and its treatment options. Moreover, increase in demand for safe and effective treatment and rise in research and development around the world is expected to boost the growth of the market. However, factors such as adverse effects of migraine drugs and lack of proper diagnosis and increasing undiagnosed cases are expected to hamper the growth of the global migraine therapeutic market.

Global Migraine Therapeutic Market Trends:

Increase in focus on disease diagnosis is a recent trend

The field of migraine has seen many new advances that have the potential to improve diagnosis and provide more personalized treatments for this condition. New treatments are rapidly becoming available to patients, raising awareness of the complexity of brain diseases, which often overlooked and under-managed. Migraines are difficult to treat, but there have been a number of advancements recently that have revealed new and exciting potential treatments. This in turn is expected to drive the growth of the global migraine therapeutic market.

Increase in consumer awareness is another trend

Although migraine sufferers are aware of their headaches, they are often not aware that they have a migraine. This can lead to inappropriate and/or ineffective use of treatments, delays in receiving appropriate care, and miscommunication during clinical encounters. June is National Migraine & Headache Awareness Month (MHAM), and the full headache, migraine, and cluster communities are working together for our diseases to be recognized. This trend is expected to continue over the forecast period, driving the growth of the market.